Trials / Completed
CompletedNCT01047176
Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI) With Drug Eluting Stent (DES) Implantation Who Take Statins
Observational Prospective Study to esTIMAte the Rates of Outcomes in Patients Undergoing PCI With Drug Eluting Stent (DES) Implantation Who Take Statins
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 602 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To estimate the rates of percutaneous coronary intervention (PCI) outcomes in patients after drug-eluting stents implantation who take statins.
Conditions
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-01-12
- Last updated
- 2012-03-01
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01047176. Inclusion in this directory is not an endorsement.